8-CPT-cAMP

Lipophilic activator of both cAMP- and cGMP- dependent protein kinase. Higher activation potential compared to cAMP; excellent cell membrane permeability, improved phosphodiesterase stability and high site selectivity preferring site B of cAK type II.
Caution: This analogue is not selective but activates cGMP-dependent protein kinase as well! In addition, it increases basal cGMP level by inhibition of PDE V.
For specific cAMP pathway activation the highly permeant Sp-5,6-DCl-cBIMPS (Prod. No. BLG-D014)  is the better choice.

BLG-C010-500 (5 x 100 µmol pack size) is not sold in the U.S. or Canada. Please contact us for available options.